Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
06.01. | LEE'S PHARM (00950): SUPPLEMENTAL ANNOUNCEMENT - INSIDE INFORMATION - LAND RESUMPTION | 5 | HKEx | ||
30.12.24 | LEE'S PHARM (00950): INSIDE INFORMATION - LAND RESUMPTION | 1 | HKEx | ||
14.10.24 | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - POTENTIAL ACCEPTANCE NOTICE OF INVESTIGATIONAL NEW DRUG APPLICATION OF RECOMBINANT ANFIBATIDE INJECTION | - | HKEx | ||
19.09.24 | LEE'S PHARM (00950): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT | 1 | HKEx | ||
19.09.24 | LEE'S PHARM (00950): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT | 1 | HKEx | ||
LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
19.09.24 | LEE'S PHARM (00950): INTERM REPORT 2024 | - | HKEx | ||
12.09.24 | Dividendenbekanntmachungen (12.09.2024) | 9.078 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,7 USD EUR AIR NEW ZEALAND LIMITED NZAIRE0001S2 0,015 NZD 0,0083 EUR ALAMOS GOLD INC CA0115321089 0... ► Artikel lesen | |
28.08.24 | LEE'S PHARM (00950): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024 | - | HKEx | ||
28.08.24 | LEE'S PHARM (00950): INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 | 1 | HKEx | ||
16.08.24 | LEE'S PHARM (00950): NOTICE OF BOARD MEETING | 1 | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GILEAD SCIENCES | 92,20 | +0,42 % | Cognizant Expands Partnership With Gilead Sciences To Enhance Efficiency And AI Integration | TEANECK (dpa-AFX) - Cognizant (CTSH) Thursday announced that it has expanded its long-standing collaboration with Gilead Sciences (GILD) to enhance cost efficiency and productivity. The partnership... ► Artikel lesen | |
ZOETIS | 166,56 | +1,88 % | Zoetis Inc. (ZTS): A Bull Case Theory | ||
SINOPHARM | 2,514 | +0,68 % | Leichte Zugewinne bei der Sinopharm Group-Aktie (2,569 €) | An der Börse notiert das Wertpapier der Sinopharm Group aktuell fester. Die Aktie kostete zuletzt 2,57 Euro. Jahreschart der Sinopharm Group Ltd.-Aktie, Stand 06.01.2025 Freuen können sich gegenwärtig... ► Artikel lesen | |
CSPC PHARMA | 0,553 | +0,51 % | CSPC PHARMA (01093): NEXT DAY DISCLOSURE RETURNS | ||
WUXI BIOLOGICS | 2,353 | +2,64 % | WuXi Biologics-Aktie leicht im Plus (2,09 €) | Das Wertpapier von WuXi Biologics notiert am Donnerstag etwas fester. Das Wertpapier kostete zuletzt 2,09 Euro. Jahreschart der WuXi Biologics Inc-Aktie, Stand 09.01.2025 Freuen können sich gegenwärtig... ► Artikel lesen | |
SHANGHAI FOSUN PHARMACEUTICAL | 1,582 | -2,59 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION | ||
DR REDDYS | 13,000 | +1,56 % | Dr. Reddy's Q3 & 9MFY25 Financial Results | HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter and... ► Artikel lesen | |
GEDEON RICHTER | 25,360 | -0,86 % | Gedeon-Richter will Versorgung bei Endometriose verbessern | ||
MEDIPHARM LABS | 0,040 | -8,29 % | MediPharm Labs Corp.: MediPharm Labs Reports Third Quarter Results | Strong Growth in International GMP Medical Markets
TORONTO, Nov. 14, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm"... ► Artikel lesen | |
ASPEN PHARMACARE | 8,800 | -3,83 % | Dividendenbekanntmachungen (18.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASPEN PHARMACARE HOLDINGS LIMITED ZAE000066692 3,59 ZAR 0,1836 EUR AUCKLAND INTERNATIONAL AIRPORT LIMITED NZAIAE0002S6 0,065 NZD 0... ► Artikel lesen | |
SHANGHAI PHARMACEUTICALS | 1,520 | -0,65 % | SH PHARMA (02607): CONNECTED TRANSACTION PROPOSED PARTICIPATION IN THE ESTABLISHMENT OF THE BIOMEDICAL M&A FUND | ||
LUYE PHARMA | 0,256 | -4,48 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED FOR THE PHASE 2 CLINICAL STUDY OF THE GROUP'S NEW DRUG LY03015 IN CHINA | ||
SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,068 | 0,00 % | Dividendenbekanntmachungen (27.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen | |
CHINA RESOURCES PHARMACEUTICAL | 0,625 | 0,00 % | CHINARES PHARMA (03320): ANNOUNCEMENT PRINCIPAL OPERATING RESULTS ESTIMATE OF JIANGZHONG PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2024 | ||
CHINA SHINEWAY PHARMACEUTICAL GROUP | 1,000 | -5,66 % | SHINEWAY PHARM (02877): TURNOVER FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024 |